Business·Industry

Peptron, Inc. Applies for Building Modification Permit for Osong Plant No. 2… Total Floor Area to Be Expanded by 2.5 Times

Reflecting the Expansion of Production and Support Facilities… Contractor to Be Selected After Permission Is Granted

KIM SAE-MI
2026-07-24 15:44:02
Exterior view of Peptron, Inc.’s Daejeon headquarters (Photo courtesy of Peptron, Inc.)

[Edaily Reporter KIM SAE-MI ] Peptron ( Peptron, Inc.(087010)) announced on the 24th that it has applied for a building modification permit to reflect design changes aimed at expanding production and support facilities at its Osong Bio Park Plant No. 2.

According to the proposed changes, the total floor area of Plant No. 2 will be expanded 2.5 times, from the current approximately 12,000 square meters to approximately 30,000 square meters. The company expects that expanding the plant’s scale will enhance the utilization of its production and support facilities.

Peptron, Inc. is proceeding with follow-up procedures, such as selecting a construction contractor, alongside the permit amendment process. Future key developments will be disclosed in accordance with relevant laws and regulations. However, specific design details and facility configurations were not disclosed.

A Peptron, Inc. official stated, “Since the detailed design specifications and facility configuration related to the building modification permit constitute commercially sensitive information tied to the company’s production technology and operational strategy, it is difficult to disclose specific details,” adding, “We will continue to provide updates on matters that can be disclosed, within the scope of compliance with relevant laws and regulations.”

Economy

Corporation

IT·Science

Economy

[Market In] “Unlocking 134.1 Billion in Dormant Assets”… DaelimTrading’s ‘Complete Transformation’ for the First Time in 56 Years

Lee Sang-won, CEO of Daelim Trading ( DaelimTrading(006570) ), announced his ambition to significantly improve the company’s financial structure and revitalize its core business by realizing the value…
2026-09-10 04:52:04

Corporation

The 'Data on Therapeutic Effects' Kim Seung-won Claimed to Have Seen… Turned Out Not to Be a Formal Research Paper

Kim Seung-won, the nominee for Minister of Justice, addressed the controversy surrounding the request for expedited processing of clinical trials for GenenCell’s COVID-19 treatment “ES16001,” explaini…
2026-09-10 08:02:03

IT·Science

Yuhan Corporation’s New Drug, Stalled for Four Years, Seeks Technology Export… “500 Billion Won Jackpot” Opportunity to Be Decided Within a Year

(Graphic: ChatGPT) Yuhan(000100)The fate of the new drug candidate “PCS12852” (Yuhan Corporation’s development code: YH12852), which Yuhan Corporation licensed to U.S.-based Processa Pharmaceutica…
2026-09-10 08:16:04